Mineralys Therapeutics News

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom

Apr 16 04:29

Mineralys Therapeutics | EFFECT: Others

Apr 12 18:07

Mineralys Therapeutics | 424B5: Prospectus

Apr 12 04:42

Mineralys Therapeutics | ARS: Annual Report to Security Holders

Apr 9 19:24

Mineralys Therapeutics | DEFA14A: Others

Apr 9 19:20

Mineralys Therapeutics | DEF 14A: Definitive information statements

Apr 9 19:19

Mineralys Therapeutics | 8-K: Current report

Apr 4 20:05

Mineralys Therapeutics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

Mar 30 04:48

Mineralys Therapeutics | 8-K: Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Mar 21 19:46

Mineralys Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 21 19:36

Mineralys Therapeutics | 10-K: Annual report

Mar 21 19:21

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom

Mar 14 05:40

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom

Feb 16 05:28

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levy Adam Scott

Feb 16 05:28

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Congleton Jon

Feb 16 05:28

Mineralys Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(6.4%),TCG Crossover Fund II, L.P.(6.4%), etc.

Feb 16 05:23

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director AKKARAJU SRINIVAS

Feb 15 10:08

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Samsara BioCapital GP, LLC

Feb 15 10:08

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Feb 15 08:53

Mineralys Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adams Street Partners, LLC(5.60%),Adams Street Growth Equity Fund VII LP(2.17%), etc.

Feb 14 19:07